首页 > 最新文献

Gastroenterologie Clinique Et Biologique最新文献

英文 中文
Multinodular fatty sparing 多结节性脂肪保留
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.07.019
M. Garetier , C. Delluc , J. Rousset , S. Chinellato , C. Sandillon-Garetier , J.-A. Bronstein
{"title":"Multinodular fatty sparing","authors":"M. Garetier , C. Delluc , J. Rousset , S. Chinellato , C. Sandillon-Garetier , J.-A. Bronstein","doi":"10.1016/j.gcb.2010.07.019","DOIUrl":"10.1016/j.gcb.2010.07.019","url":null,"abstract":"","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 651-652"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.07.019","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29281744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterotopic pancreas: An unusual cause of epigastric pain 异位胰腺:引起胃脘痛的不寻常原因
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.09.005
S. Reggoug , I. Errabih , L. Ouazzani , N. Benzzoubeir , H. Krami , M. Raiss , A. Hrora , M. Ahallat , H. Ouazzani
{"title":"Heterotopic pancreas: An unusual cause of epigastric pain","authors":"S. Reggoug , I. Errabih , L. Ouazzani , N. Benzzoubeir , H. Krami , M. Raiss , A. Hrora , M. Ahallat , H. Ouazzani","doi":"10.1016/j.gcb.2010.09.005","DOIUrl":"10.1016/j.gcb.2010.09.005","url":null,"abstract":"","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 726-727"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.09.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29375731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Stem cells and colon cancer: The questionable cancer stem cell hypothesis 干细胞和结肠癌:可疑的癌症干细胞假说
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.08.014
C. Gespach

The fine-tuning between cell proliferation and differentiation of self-renewing stem cells and pluripotent progenitors in gastric glands and colon epithelial crypts is coordinated by the mechanisms that regulate colon epithelial cell migration and guidance along the crypt axis. This leads to the acquisition of specialized cellular functions and the exfoliation of desquamated senescent and apoptotic epithelial cells at the apical mucosa interface with the gut lumen. Self-renewing stem cells and pluripotent progenitors are involved in the clonal and polyclonal growth of digestive tumors. Several lines of evidence support the existence of a subpopulation of cancer cells with stem cell-like (SCL) phenotypes in solid tumors of breast and digestive system. Consistently, epithelial cancer cell lines in long-term culture are phenotypically and functionally heterogeneous. It is suggested that only a small proportion of transformed cells are clonogenic in vivo and ex vivo to form colonies and to initiate tumor growth in immunodeficient mice. A discrete subpopulation of tumor -initiating SCL cancer cells are highly competent to survive, propagate and spread through the invasive and metastatic cascade. A better understanding of the mechanisms driving the plasticity and pluripotency of stem cells, their derived progenitors and SCL colon cancer initiating cells during tumor progression will open new avenues for the early detection and treatment of local and distant tumors of the digestive tract.

胃腺和结肠上皮隐窝中自我更新干细胞和多能祖细胞的增殖和分化之间的微调是通过调节结肠上皮细胞沿隐窝轴迁移和引导的机制来协调的。这导致获得特殊的细胞功能,并导致脱落的衰老和凋亡上皮细胞在肠腔的顶端粘膜界面脱落。自我更新的干细胞和多能祖细胞参与消化道肿瘤的克隆和多克隆生长。一些证据支持在乳腺和消化系统实体瘤中存在具有干细胞样表型(SCL)的癌细胞亚群。长期培养的上皮癌细胞系在表型和功能上都是异质的。提示只有一小部分转化后的细胞在体内和体外具有克隆性,从而在免疫缺陷小鼠体内形成菌落并启动肿瘤生长。一个离散的肿瘤启动SCL癌细胞亚群在侵袭性和转移性级联中具有高度的生存、繁殖和扩散能力。更好地了解肿瘤进展过程中驱动干细胞、其衍生祖细胞和SCL结肠癌起始细胞的可塑性和多能性的机制,将为消化道局部和远处肿瘤的早期发现和治疗开辟新的途径。
{"title":"Stem cells and colon cancer: The questionable cancer stem cell hypothesis","authors":"C. Gespach","doi":"10.1016/j.gcb.2010.08.014","DOIUrl":"10.1016/j.gcb.2010.08.014","url":null,"abstract":"<div><p>The fine-tuning between cell proliferation and differentiation of self-renewing stem cells and pluripotent progenitors in gastric glands and colon epithelial crypts is coordinated by the mechanisms that regulate colon epithelial cell migration and guidance along the crypt axis. This leads to the acquisition of specialized cellular functions and the exfoliation of desquamated senescent and apoptotic epithelial cells at the apical mucosa interface with the gut lumen. Self-renewing stem cells and pluripotent progenitors are involved in the clonal and polyclonal growth of digestive tumors. Several lines of evidence support the existence of a subpopulation of cancer cells with stem cell-like (SCL) phenotypes in solid tumors of breast and digestive system. Consistently, epithelial cancer cell lines in long-term culture are phenotypically and functionally heterogeneous. It is suggested that only a small proportion of transformed cells are clonogenic in vivo and ex vivo to form colonies and to initiate tumor growth in immunodeficient mice. A discrete subpopulation of tumor -initiating SCL cancer cells are highly competent to survive, propagate and spread through the invasive and metastatic cascade. A better understanding of the mechanisms driving the plasticity and pluripotency of stem cells, their derived progenitors and SCL colon cancer initiating cells during tumor progression will open new avenues for the early detection and treatment of local and distant tumors of the digestive tract.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 653-661"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.08.014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29447089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Circulating free tumor DNA and colorectal cancer 循环游离肿瘤DNA和结直肠癌
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2009.04.015
T. Lecomte , N. Ceze , É. Dorval , P. Laurent-Puig

Cancer is characterized by multiple somatic genetic and epigenetic alterations that could be useful as molecular markers for detecting tumor DNA in different bodily fluids. In patients with various diseases as well as in healthy subjects, circulating plasma and serum carry small amounts of non-cell-bound DNA. In this free circulating DNA, tumor-associated molecular alterations can be detected in patients who have cancer. In many instances, the alterations identified are the same as those found in the primary tumor tissue, thereby suggesting tumor origin from a fraction of the circulating free DNA. In fact, various types of DNA alterations described in colorectal cancer have been detected in the circulating free DNA of patients with colorectal cancer. These alterations include KRAS2, APC and TP53 mutations, DNA hypermethylation, microsatellite instability (MSI) and loss of heterozygosity (LOH). Also, advances in polymerase chain reaction (PCR)-based technology now allow the detection and quantification of extremely small amounts of tumor-derived circulating free DNA in colorectal cancer patients. The present report summarizes the literature available so far on the mechanisms of circulating free DNA, and on the studies aimed at assessing the clinical and biological significance of tumor-derived circulating free DNA in colorectal cancer patients. Thus, tumor-derived circulating free DNA could serve as a marker for the diagnosis, prognosis and early detection of recurrence, thereby significantly improving the monitoring of colorectal cancer patients.

Les altérations génétiques ou épigénétiques somatiques des cellules tumorales constituent un moyen d’identification moléculaire de la présence d’ADN tumoral dans un prélèvement biologique. De l’ADN libre est présent dans le sang et, chez les patients atteints de cancer, une fraction de cet ADN est d’origine tumorale. Chez des patients atteints de cancer, l’origine tumorale d’une fraction de l’ADN libre circulant a été démontrée au moyen de la détection d’altérations génétiques de l’ADN libre circulant plasmatique et/ou sérique identiques à celles mises en évidence au niveau de l’ADN extrait de la tumeur. Les altérations génétiques et épigénétiques les plus communes décrites dans le cancer colorectal ont été détectées au niveau de l’ADN libre circulant plasmatique et/ou sérique de patients atteints de cancer colorectal. Il s’agit principalement de mutations de l’oncogène KRAS2, de mutations des gènes suppresseurs de tumeurs APC et TP53, d’altérations de marqueurs microsatellites et d’anomalies de la méthylation de l’ADN tumoral. Grâce aux développements technologiques considérables réalisés dans le domaine de l’analyse de l’ADN, la recherche de nouveaux biomarqueurs du cancer colorectal basée sur la détection de l’ADN libre d’origine tumorale sérique ou plasmatique ou extrait d’autres prélèvements biologiques ouvre de nouvelles

癌症的特征是多种体细胞遗传和表观遗传改变,这些改变可以作为检测不同体液中肿瘤DNA的分子标记。在各种疾病患者和健康受试者中,循环血浆和血清携带少量非细胞结合DNA。在这种自由循环的DNA中,肿瘤相关的分子改变可以在癌症患者中检测到。在许多情况下,发现的改变与在原发肿瘤组织中发现的相同,从而表明肿瘤起源于循环游离DNA的一小部分。事实上,在结直肠癌患者的循环游离DNA中已经检测到结直肠癌中描述的各种类型的DNA改变。这些改变包括KRAS2、APC和TP53突变、DNA超甲基化、微卫星不稳定性(MSI)和杂合性缺失(LOH)。此外,基于聚合酶链反应(PCR)技术的进步现在可以检测和定量结直肠癌患者体内极少量的肿瘤来源的循环游离DNA。本文综述了迄今为止关于游离DNA循环机制的文献,以及旨在评估肿瘤来源的游离DNA在结直肠癌患者中的临床和生物学意义的研究。因此,肿瘤来源的循环游离DNA可以作为诊断、预后和早期发现复发的标志物,从而显著提高对结直肠癌患者的监测。Les改变genetiques ou epigenetiques somatiques des小房tumorales组成联合国平均d 'identification moleculaire de la存在d 'ADN tumoral在prelevement biologique。ADN的游离性检测结果表明,ADN的游离性检测结果表明,ADN的游离性检测结果表明,ADN的游离性检测结果表明,ADN的游离性检测结果表明,ADN的游离性检测结果表明:癌症患者,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发,肿瘤原发Les altsamats, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac, samac研究结果包括:肿瘤KRAS2基因突变、肿瘤APC和TP53基因抑制基因突变、肿瘤adn基因突变、肿瘤adn基因突变、肿瘤adn基因突变、肿瘤adn基因突变和肿瘤adn基因突变。恩典辅助开发署technologiques相当意识到在domaine de分析de l 'ADN,说是德新biomarqueurs du癌症结直肠basee苏尔la检测de l 'ADN自由泳d’origine tumorale serique ou plasmatique ou extrait其他prelevements以及ouvre de新式voies pour la协定盟德测试点就相对简单等一些onereux倒le depistage le诊断precoce de recidiveL '升职升职升职升职升职升职升职升职升职升职升职升职
{"title":"Circulating free tumor DNA and colorectal cancer","authors":"T. Lecomte ,&nbsp;N. Ceze ,&nbsp;É. Dorval ,&nbsp;P. Laurent-Puig","doi":"10.1016/j.gcb.2009.04.015","DOIUrl":"10.1016/j.gcb.2009.04.015","url":null,"abstract":"<div><p>Cancer is characterized by multiple somatic genetic and epigenetic alterations that could be useful as molecular markers for detecting tumor DNA in different bodily fluids. In patients with various diseases as well as in healthy subjects, circulating plasma and serum carry small amounts of non-cell-bound DNA. In this free circulating DNA, tumor-associated molecular alterations can be detected in patients who have cancer. In many instances, the alterations identified are the same as those found in the primary tumor tissue, thereby suggesting tumor origin from a fraction of the circulating free DNA. In fact, various types of DNA alterations described in colorectal cancer have been detected in the circulating free DNA of patients with colorectal cancer. These alterations include <em>KRAS2</em>, <em>APC</em> and <em>TP53</em> mutations, DNA hypermethylation, microsatellite instability (MSI) and loss of heterozygosity (LOH). Also, advances in polymerase chain reaction (PCR)-based technology now allow the detection and quantification of extremely small amounts of tumor-derived circulating free DNA in colorectal cancer patients. The present report summarizes the literature available so far on the mechanisms of circulating free DNA, and on the studies aimed at assessing the clinical and biological significance of tumor-derived circulating free DNA in colorectal cancer patients. Thus, tumor-derived circulating free DNA could serve as a marker for the diagnosis, prognosis and early detection of recurrence, thereby significantly improving the monitoring of colorectal cancer patients.</p></div><div><p>Les altérations génétiques ou épigénétiques somatiques des cellules tumorales constituent un moyen d’identification moléculaire de la présence d’ADN tumoral dans un prélèvement biologique. De l’ADN libre est présent dans le sang et, chez les patients atteints de cancer, une fraction de cet ADN est d’origine tumorale. Chez des patients atteints de cancer, l’origine tumorale d’une fraction de l’ADN libre circulant a été démontrée au moyen de la détection d’altérations génétiques de l’ADN libre circulant plasmatique et/ou sérique identiques à celles mises en évidence au niveau de l’ADN extrait de la tumeur. Les altérations génétiques et épigénétiques les plus communes décrites dans le cancer colorectal ont été détectées au niveau de l’ADN libre circulant plasmatique et/ou sérique de patients atteints de cancer colorectal. Il s’agit principalement de mutations de l’oncogène <em>KRAS2</em>, de mutations des gènes suppresseurs de tumeurs <em>APC</em> et <em>TP53</em>, d’altérations de marqueurs microsatellites et d’anomalies de la méthylation de l’ADN tumoral. Grâce aux développements technologiques considérables réalisés dans le domaine de l’analyse de l’ADN, la recherche de nouveaux biomarqueurs du cancer colorectal basée sur la détection de l’ADN libre d’origine tumorale sérique ou plasmatique ou extrait d’autres prélèvements biologiques ouvre de nouvelles","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 662-681"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2009.04.015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40061374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Feasibility and safety of granulocytapheresis in Crohn's disease: A prospective cohort study 克罗恩病粒细胞清除术的可行性和安全性:一项前瞻性队列研究
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.09.009
G. Bresci , A. Romano , A. Mazzoni , F. Scatena , E. Altomare , A. Capria , R. Sacco

Background and objective

This study evaluated the feasibility and safety of granulocytapheresis (GCAP) in inducing and maintaining remission in refractory Crohn's disease. The relationship between the clinical outcomes and the location (ileal or ileocolonic) of disease was also assessed.

Patients

We evaluated 16 patients with ileal location (group A), 14 with ileocolonic location (group B). The patients underwent five sessions (1 session/wk) of GCAP (AdacolumnTM). CDAI was measured at the end of the GCAP, at 6, 9 and 12 months.

Results and conclusions

No major complications were observed. At the end of GCAP, 19 (63.3%) patients showed a clinical remission: 10 (62.5%) in group A versus 9 (64.2%) in group B. At 6 months, 16 (53.3%) of the cases had maintained remission: 9 (56.2%) in group A versus 7 (50.0%) in group B. At 9 months, 13 (43.3%) patients had maintained remission: 7 (43.7%) in group A versus 6 (42.8%) in group B. At 12 months, 12 (40%) patients were still in clinical remission: 7 (43.7%) in group A versus 5 (35.7%) in group B. Risk of relapse was not related to disease location. The procedure was well tolerated and feasible in an important percentage of Crohn's disease patients.

背景与目的本研究评价粒细胞清除术(GCAP)诱导和维持难治性克罗恩病缓解的可行性和安全性。临床结果与疾病位置(回肠或回肠结肠)之间的关系也被评估。患者:我们评估了16例回肠定位患者(A组),14例回肠结肠定位患者(B组)。患者接受了5次(1次/周)GCAP (adacollumtm)。在GCAP结束、6、9和12个月时测量CDAI。结果与结论本组无重大并发症。GCAP结束时,19例(63.3%)患者出现临床缓解:a组10例(62.5%),b组9例(64.2%)。6个月时,16例(53.3%)患者维持缓解;a组9例(56.2%),b组7例(50.0%)。9个月时,13例(43.3%)患者维持缓解;a组7例(43.7%),b组6例(42.8%)。12个月时,12例(40%)患者仍处于临床缓解。A组7例(43.7%),b组5例(35.7%),复发风险与发病部位无关。该手术在很大比例的克罗恩病患者中具有良好的耐受性和可行性。
{"title":"Feasibility and safety of granulocytapheresis in Crohn's disease: A prospective cohort study","authors":"G. Bresci ,&nbsp;A. Romano ,&nbsp;A. Mazzoni ,&nbsp;F. Scatena ,&nbsp;E. Altomare ,&nbsp;A. Capria ,&nbsp;R. Sacco","doi":"10.1016/j.gcb.2010.09.009","DOIUrl":"10.1016/j.gcb.2010.09.009","url":null,"abstract":"<div><h3>Background and objective</h3><p>This study evaluated the feasibility and safety of granulocytapheresis (GCAP) in inducing and maintaining remission in refractory Crohn's disease. The relationship between the clinical outcomes and the location (ileal or ileocolonic) of disease was also assessed.</p></div><div><h3>Patients</h3><p>We evaluated 16 patients with ileal location (group A), 14 with ileocolonic location (group B). The patients underwent five sessions (1 session/wk) of GCAP (Adacolumn<sup>TM</sup>). CDAI was measured at the end of the GCAP, at 6, 9 and 12 months.</p></div><div><h3>Results and conclusions</h3><p>No major complications were observed. At the end of GCAP, 19 (63.3%) patients showed a clinical remission: 10 (62.5%) in group A versus 9 (64.2%) in group B. At 6 months, 16 (53.3%) of the cases had maintained remission: 9 (56.2%) in group A versus 7 (50.0%) in group B. At 9 months, 13 (43.3%) patients had maintained remission: 7 (43.7%) in group A versus 6 (42.8%) in group B. At 12 months, 12 (40%) patients were still in clinical remission: 7 (43.7%) in group A versus 5 (35.7%) in group B. Risk of relapse was not related to disease location. The procedure was well tolerated and feasible in an important percentage of Crohn's disease patients.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 682-686"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.09.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29467951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Transcatheter local thrombolysis in patients with extensive TIPS thrombosis 广泛TIPS血栓形成患者经导管局部溶栓
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.07.011
J. Dumortier , T. Walter , O. Guillaud , F. Pietu , M. Vallin , L. Henry , F. Pilleul

Background

Transcatheter local thrombolytic therapy in patients with portosplanchnic venous thrombosis has been used in few cases.

Case reports

Here, we present our single-center experience with transcatheter thrombolytic therapy in three patients with extensive refractory portal and transjugular intrahepatic portosystemic shunt (TIPS) thrombosis. Thrombolytic therapy was successful for all three patients. Two patients developed minor procedure-related bleeding.

Conclusion

Local thrombolysis could be proposed in case of TIPS thrombosis for patients in whom the venous flow cannot be restored by using conventional anticoagulant therapy and stent mechanical revision.

背景经导管局部溶栓治疗门静脉血栓的病例很少。病例报告:在这里,我们介绍了我们的单中心经验,经导管溶栓治疗3例广泛难治性门静脉和经颈静脉肝内门静脉系统分流(TIPS)血栓形成。溶栓治疗对三例患者均成功。两名患者出现轻微的手术相关出血。结论对于常规抗凝治疗和支架机械翻修不能恢复静脉血流的TIPS血栓形成患者,可采用局部溶栓治疗。
{"title":"Transcatheter local thrombolysis in patients with extensive TIPS thrombosis","authors":"J. Dumortier ,&nbsp;T. Walter ,&nbsp;O. Guillaud ,&nbsp;F. Pietu ,&nbsp;M. Vallin ,&nbsp;L. Henry ,&nbsp;F. Pilleul","doi":"10.1016/j.gcb.2010.07.011","DOIUrl":"10.1016/j.gcb.2010.07.011","url":null,"abstract":"<div><h3>Background</h3><p>Transcatheter local thrombolytic therapy in patients with portosplanchnic venous thrombosis has been used in few cases.</p></div><div><h3>Case reports</h3><p>Here, we present our single-center experience with transcatheter thrombolytic therapy in three patients with extensive refractory portal and transjugular intrahepatic portosystemic shunt (TIPS) thrombosis. Thrombolytic therapy was successful for all three patients. Two patients developed minor procedure-related bleeding.</p></div><div><h3>Conclusion</h3><p>Local thrombolysis could be proposed in case of TIPS thrombosis for patients in whom the venous flow cannot be restored by using conventional anticoagulant therapy and stent mechanical revision.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 721-725"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.07.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29342046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple intestinal perforation in a patient with Wegener's granulomatosis: A case report and review of the literature 韦格纳肉芽肿患者多发肠穿孔1例报告及文献复习
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.08.009
A.C. Yildirim , E. Koçak , P. Yildiz , M. Yildiz , A.Ş. Karakayalı , B. Kaptanoglu , S. Köklü

Wegener's granulomatosis is a necrotizing vasculitis of unknown etiology characterized mainly by inflammation of the small- and medium-sized arteries and veins that affect any viscera. It may rarely involve the gastrointestinal tract. Only a few cases of multiple focus ileal perforation due to ulcers associated with Wegener's granulomatosis have been reported. Herein we report a case of a 32-year-old man with extensive intestinal small bowel ischaemic perforation due to Wegener's granulomatosis.

韦格纳肉芽肿病是一种病因不明的坏死性血管炎,主要表现为影响任何脏器的中小动脉和静脉的炎症。它很少累及胃肠道。只有少数病例的多灶回肠穿孔由于溃疡与韦格纳肉芽肿病已被报道。我们在此报告一位32岁男性,因韦格纳肉芽肿病而出现广泛的小肠缺血性穿孔。
{"title":"Multiple intestinal perforation in a patient with Wegener's granulomatosis: A case report and review of the literature","authors":"A.C. Yildirim ,&nbsp;E. Koçak ,&nbsp;P. Yildiz ,&nbsp;M. Yildiz ,&nbsp;A.Ş. Karakayalı ,&nbsp;B. Kaptanoglu ,&nbsp;S. Köklü","doi":"10.1016/j.gcb.2010.08.009","DOIUrl":"10.1016/j.gcb.2010.08.009","url":null,"abstract":"<div><p>Wegener's granulomatosis is a necrotizing vasculitis of unknown etiology characterized mainly by inflammation of the small- and medium-sized arteries and veins that affect any viscera. It may rarely involve the gastrointestinal tract. Only a few cases of multiple focus ileal perforation due to ulcers associated with Wegener's granulomatosis have been reported. Herein we report a case of a 32-year-old man with extensive intestinal small bowel ischaemic perforation due to Wegener's granulomatosis.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 712-715"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.08.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29314760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Colonoscopy practices, and colorectal cancer and polyp screening, as assessed in the French district of Isère from May to July in 2004 结肠镜检查、结直肠癌和息肉筛查,2004年5月至7月在法国is<e:1>区进行评估
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2009.09.008
C. Exbrayat , F. Poncet , A. Billette de Villemeur , A. Garnier , P. Bureau du Colombier

Background

A pilot program of organized screening for colorectal cancers was conducted in Isère, an administrative district in France. A fecal occult blood test (Hemoccult II®) was proposed for all individuals aged greater than 50 years (women since 1991 and men since 2002), followed by colonoscopy for those testing positive. A prospective study was carried out from May to July in 2004 and compared with a similar study conducted in 1996. The goal was to investigate colonoscopy practices, especially the role of screening.

Methods

Gastroenterologists practising in Isère (n = 39/42 practitioners) completed a questionnaire including their patients’ age and gender, indications, methods and results for all colonoscopies performed in those aged greater than 20 years. Any tissue samples taken were sent away for histological evaluation.

Results

The study involved 2558 colonoscopies (54% female, 73% patients aged greater or equal to 50 years), an increase of 35% from 1996 to 2004. Of the patients referred, 50.0% were symptomatic (pain; bowel problems: 28.7%; rectal bleeding: 21.3%), 23.5% had colonic disease and 22.5% came from screening (3.1% had positive stool tests, 17.8% had a family history). Recommendations related to family history (update of the 1998 consensus conference: screening indicated for patients with a first-degree relative diagnosed with cancer or advanced polyps aged less than 60 years) were well applied in terms of relatedness (81%) but, in 52% of cases, the age was greater than 60 years. Colonoscopy was carried out in almost all cases (0.1% failure), with complications in 0.4% of the examinations. Of the 2558 colonoscopies performed, 10% revealed advanced polyps or cancer: 30% were following a positive test compared with 8% for symptoms and 6% with a family history. Multivariate analyses showed that polyps greater or equal to 10 mm or malignant tumors are 1.5 times more common in men than in women, and six times more frequently seen in patients having colonoscopy following a positive test for blood in stools than in those with a family history of colorectal cancer. The number of pathologies found increased significantly in those aged greater than 50 years.

Conclusion

This cross-sectional survey of colonoscopy practices in Isère shows an increase in the number of colonoscopies performed between 1996 and 2004. This increase is not explained by expansion of the screening program, which was the reason for only 3% of colonoscopies. However, the best diagnostic yield for advanced polyps or cancers was obtained in screened patients (30%).

背景:在法国的is区开展了一项有组织的结直肠癌筛查试点项目。建议对所有年龄大于50岁的人(1991年以来为女性,2002年以来为男性)进行粪便隐血检查(Hemoccult II®),然后对检测阳性的人进行结肠镜检查。2004年5月至7月进行了一项前瞻性研究,并与1996年进行的一项类似研究进行了比较。目的是调查结肠镜检查的实践,特别是筛查的作用。方法在is执业的胃肠病学家(39/42)填写一份问卷,包括年龄大于20岁的患者的年龄、性别、适应症、方法和结果。所有组织样本都被送去做组织学评估。结果本研究共纳入2558例结肠镜检查,其中女性占54%,年龄大于等于50岁的患者占73%,1996 - 2004年增加了35%。在转诊的患者中,50.0%有症状(疼痛;肠道问题:28.7%;直肠出血:21.3%),23.5%有结肠疾病,22.5%来自筛查(3.1%大便检查呈阳性,17.8%有家族史)。与家族史相关的建议(1998年共识会议的更新:对年龄小于60岁的一级亲属诊断为癌症或晚期息肉的患者进行筛查)在亲属关系方面得到了很好的应用(81%),但在52%的病例中,年龄大于60岁。结肠镜检查几乎在所有的病例(0.1%失败)中进行,有0.4%的检查出现并发症。在进行的2558次结肠镜检查中,10%发现了晚期息肉或癌症:30%的检查呈阳性,8%的检查有症状,6%的检查有家族史。多变量分析显示,大于或等于10mm的息肉或恶性肿瘤在男性中的发生率是女性的1.5倍,在粪便血检测呈阳性的结肠镜检查患者中的发生率是有结直肠癌家族史患者的6倍。在年龄大于50岁的人群中发现的病理数量显著增加。结论:这项对以色列结肠镜检查实践的横断面调查显示,1996年至2004年结肠镜检查的数量有所增加。这种增长不能用筛查项目的扩大来解释,筛查项目的扩大是只有3%的结肠镜检查的原因。然而,晚期息肉或癌症的最佳诊断率是在筛查的患者中获得的(30%)。
{"title":"Colonoscopy practices, and colorectal cancer and polyp screening, as assessed in the French district of Isère from May to July in 2004","authors":"C. Exbrayat ,&nbsp;F. Poncet ,&nbsp;A. Billette de Villemeur ,&nbsp;A. Garnier ,&nbsp;P. Bureau du Colombier","doi":"10.1016/j.gcb.2009.09.008","DOIUrl":"10.1016/j.gcb.2009.09.008","url":null,"abstract":"<div><h3>Background</h3><p>A pilot program of organized screening for colorectal cancers was conducted in Isère, an administrative district in France. A fecal occult blood test (Hemoccult II<sup>®</sup>) was proposed for all individuals aged greater than 50<!--> <!-->years (women since 1991 and men since 2002), followed by colonoscopy for those testing positive. A prospective study was carried out from May to July in 2004 and compared with a similar study conducted in 1996. The goal was to investigate colonoscopy practices, especially the role of screening.</p></div><div><h3>Methods</h3><p>Gastroenterologists practising in Isère (<em>n</em> <!-->=<!--> <!-->39/42 practitioners) completed a questionnaire including their patients’ age and gender, indications, methods and results for all colonoscopies performed in those aged greater than 20<!--> <!-->years. Any tissue samples taken were sent away for histological evaluation.</p></div><div><h3>Results</h3><p>The study involved 2558 colonoscopies (54% female, 73% patients aged greater or equal to 50<!--> <!-->years), an increase of 35% from 1996 to 2004. Of the patients referred, 50.0% were symptomatic (pain; bowel problems: 28.7%; rectal bleeding: 21.3%), 23.5% had colonic disease and 22.5% came from screening (3.1% had positive stool tests, 17.8% had a family history). Recommendations related to family history (update of the 1998 consensus conference: screening indicated for patients with a first-degree relative diagnosed with cancer or advanced polyps aged less than 60<!--> <!-->years) were well applied in terms of relatedness (81%) but, in 52% of cases, the age was greater than 60<!--> <!-->years. Colonoscopy was carried out in almost all cases (0.1% failure), with complications in 0.4% of the examinations. Of the 2558 colonoscopies performed, 10% revealed advanced polyps or cancer: 30% were following a positive test compared with 8% for symptoms and 6% with a family history. Multivariate analyses showed that polyps greater or equal to 10<!--> <!-->mm or malignant tumors are 1.5 times more common in men than in women, and six times more frequently seen in patients having colonoscopy following a positive test for blood in stools than in those with a family history of colorectal cancer. The number of pathologies found increased significantly in those aged greater than 50<!--> <!-->years.</p></div><div><h3>Conclusion</h3><p>This cross-sectional survey of colonoscopy practices in Isère shows an increase in the number of colonoscopies performed between 1996 and 2004. This increase is not explained by expansion of the screening program, which was the reason for only 3% of colonoscopies. However, the best diagnostic yield for advanced polyps or cancers was obtained in screened patients (30%).</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 702-711"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2009.09.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29374759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: A report based on 120 patients with active ulcerative colitis 对吸附性白细胞清除有反应和无反应的临床和内镜特征:基于120例活动性溃疡性结肠炎患者的报告
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.08.007
Tomotaka Tanaka , Hideharu Okanobu , Yoshio Kuga , Yoshikazu Yoshifuku , Hatsue Fujino , Tomohiro Miwata , Takashi Moriya , Toshihiro Nishida , Toshihide Oya

Background and Objective

Elevated/activated myeloid leucocytes, like the CD14(+)CD16(+) monocytes are sources of TNF-α, and therefore, selective depletion of these cells by granulocyte/monocyte (GM) adsorption (GMA) should promote remission or enhance drug efficacy. However, studies in ulcerative colitis (UC) reported contrasting efficacy, from an 85% to statistically insignificant level. We investigated patients’ demography in responders and non-responders.

Methods

In 120 UC patients, 61 steroid naive and 59 steroid dependent, we looked for entry clinical or endoscopic features to identify responders (or non-responders) to GMA. Patients received up to an 11 Adacolumn GMA sessions over 12 weeks. Patients were clinically and endoscopically evaluated, allowing each patient to serve as her/his own control. Immunohistochemistry on colonic biopsies was to reveal the impact of GMA on leucocyte infiltration of the mucosa.

Results

Entry average clinical activity index (CAI) was 12.6, 10–16. An 80 of 120 patients responded (CAI  4); 45 steroid naïve (73.8%) and 35 steroid dependent (59.3%). Over 900 biopsies were processed. Infiltrating leucocytes were overwhelmingly polymorphonuclear and macrophages around and within crypt abscesses. There was a marked reduction of infiltrating leucocytes in responders. Most non-responders had extensive colonic lesions with virtually no mucosal tissue left at the lesions.

Conclusions

Steroid naïve patients with short duration of UC were the best responders, while patients with deep colonic lesions and extensive loss of the mucosal tissue were non-responders.

背景和目的升高/活化的髓系白细胞,如CD14(+)CD16(+)单核细胞是TNF-α的来源,因此,通过粒细胞/单核细胞(GM)吸附(GMA)选择性消耗这些细胞应促进缓解或增强药物疗效。然而,溃疡性结肠炎(UC)的研究报告了相反的疗效,从85%到统计学上不显著的水平。我们调查了有反应和无反应患者的人口统计学。方法在120例UC患者中,61例类固醇初治,59例类固醇依赖,我们寻找临床或内窥镜特征来识别对GMA有反应(或无反应)的患者。患者在12周内接受了11次adacolcolumn GMA治疗。对患者进行临床和内窥镜评估,允许每位患者作为自己的对照。结肠活检免疫组化观察GMA对粘膜白细胞浸润的影响。结果平均临床活动指数(CAI)为12.6,10 ~ 16。120例患者中有80例有反应(CAI≤4);45例类固醇naïve(73.8%)和35例类固醇依赖(59.3%)。处理了900多例活组织检查。隐窝脓肿周围和内部浸润的白细胞绝大多数为多形核细胞和巨噬细胞。应答者浸润性白细胞明显减少。大多数无应答者有广泛的结肠病变,几乎没有粘膜组织在病变处留下。结论使用类固醇naïve治疗持续时间短的UC患者反应最佳,而结肠深部病变和广泛粘膜组织丢失的患者无反应。
{"title":"Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: A report based on 120 patients with active ulcerative colitis","authors":"Tomotaka Tanaka ,&nbsp;Hideharu Okanobu ,&nbsp;Yoshio Kuga ,&nbsp;Yoshikazu Yoshifuku ,&nbsp;Hatsue Fujino ,&nbsp;Tomohiro Miwata ,&nbsp;Takashi Moriya ,&nbsp;Toshihiro Nishida ,&nbsp;Toshihide Oya","doi":"10.1016/j.gcb.2010.08.007","DOIUrl":"10.1016/j.gcb.2010.08.007","url":null,"abstract":"<div><h3>Background and Objective</h3><p>Elevated/activated myeloid leucocytes, like the CD14(+)CD16(+) monocytes are sources of TNF-α, and therefore, selective depletion of these cells by granulocyte/monocyte (GM) adsorption (GMA) should promote remission or enhance drug efficacy. However, studies in ulcerative colitis (UC) reported contrasting efficacy, from an 85% to statistically insignificant level. We investigated patients’ demography in responders and non-responders.</p></div><div><h3>Methods</h3><p>In 120 UC patients, 61 steroid naive and 59 steroid dependent, we looked for entry clinical or endoscopic features to identify responders (or non-responders) to GMA. Patients received up to an 11 Adacolumn GMA sessions over 12 weeks. Patients were clinically and endoscopically evaluated, allowing each patient to serve as her/his own control. Immunohistochemistry on colonic biopsies was to reveal the impact of GMA on leucocyte infiltration of the mucosa.</p></div><div><h3>Results</h3><p>Entry average clinical activity index (CAI) was 12.6, 10–16. An 80 of 120 patients responded (CAI<!--> <!-->≤<!--> <!-->4); 45 steroid naïve (73.8%) and 35 steroid dependent (59.3%). Over 900 biopsies were processed. Infiltrating leucocytes were overwhelmingly polymorphonuclear and macrophages around and within crypt abscesses. There was a marked reduction of infiltrating leucocytes in responders. Most non-responders had extensive colonic lesions with virtually no mucosal tissue left at the lesions.</p></div><div><h3>Conclusions</h3><p>Steroid naïve patients with short duration of UC were the best responders, while patients with deep colonic lesions and extensive loss of the mucosal tissue were non-responders.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 687-695"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.08.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29344635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 29
A not so solitary fibrous tumor of the liver 一种不是孤立的肝脏纤维性肿瘤
Pub Date : 2010-12-01 DOI: 10.1016/j.gcb.2010.08.004
C. Brochard , S. Michalak , C. Aubé , C. Singeorzan , H.-D. Fournier , L. Laccourreye , P. Calès , J. Boursier

Solitary fibrous tumor (SFT) is a rare neoplasm. Liver parenchyma is a rare location of SFT and, in this case, it usually follows a benign course. We report here the case of a 54-year-old man who presented a large SFT tumor of the right hepatic lobe. The tumor was surgically resected. Local recurrence occurred 6 years later as a 15 cm diameter liver tumor. Histological examination of the resected lesion showed features of an aggressive form of SFT. Two years later, the patient presented with complaints of neck pain and ensuing examinations revealed a tumor of the cranial base. A new surgical resection was performed and histological examination confirmed a metastasis of the SFT. Few weeks later, the patient presented an irreducible psoitis due to an iliac bone metastasis. He died within 1 month.

La tumeur fibreuse solitaire est une néoplasie rare. Sa localisation hépatique est peu fréquente et, dans ce cas, est le plus souvent bénigne. Nous rapportons le cas d’un homme de 54 ans ayant présenté une volumineuse tumeur fibreuse solitaire du foie droit. Après un traitement chirurgical initial la tumeur récidivait six ans plus tard sous forme d’une lésion de 15 cm. L’analyse histologique montrait des caractéristiques en faveur d’une forme agressive. Deux ans plus tard, le patient a consulté pour des cervicalgies. Les examens réalisés ont révélé une tumeur de la base du crâne. Une nouvelle résection chirurgicale a été réalisée et l’histologie était en faveur d’une métastase de la tumeur fibreuse solitaire du foie. Quelques semaines plus tard, le patient a présenté un psoïtis irréductible en lien avec une métastase osseuse iliaque. Il est décédé un mois plus tard.

孤立性纤维性肿瘤是一种罕见的肿瘤。肝实质是一个罕见的SFT的位置,在这种情况下,它通常遵循良性进程。我们在此报告一例54岁男性右肝叶SFT肿瘤。手术切除了肿瘤。6年后局部复发为直径15cm的肝肿瘤。切除病灶的组织学检查显示具有侵袭性SFT的特征。两年后,患者主诉颈部疼痛,随后检查发现颅底肿瘤。进行了新的手术切除,组织学检查证实了SFT的转移。几周后,由于髂骨转移,患者出现了无法治愈的腰椎间盘炎。他在一个月内去世了。肿瘤纤维是一种罕见的恶性肿瘤。本地化后的samsampatique测试包括:fersamquente et, dans ce cas, est le + souvent bsamenge。现在的报告显示,在54岁的孩子中,有一种人被认为是一种体积体积的肿瘤纤维,这种纤维被认为是一种健康的纤维。治疗后,手术初始肿瘤切除6厘米,切除15厘米。我来分析一下组织学上的montrait des caracacimristiques en favre 'une form aggressive。2个+ 1个,病人1个+ 1个。莱斯检查了新几内亚基地肿瘤的 基地肿瘤。一种新形式的薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金,一种薪金薪金。奎尔克semaines加塔德,我们的病人是一个变性人或psoïtis变性人,我们的病人是一个变性人或变性人。我要测试一下,你的薪金是多少?
{"title":"A not so solitary fibrous tumor of the liver","authors":"C. Brochard ,&nbsp;S. Michalak ,&nbsp;C. Aubé ,&nbsp;C. Singeorzan ,&nbsp;H.-D. Fournier ,&nbsp;L. Laccourreye ,&nbsp;P. Calès ,&nbsp;J. Boursier","doi":"10.1016/j.gcb.2010.08.004","DOIUrl":"10.1016/j.gcb.2010.08.004","url":null,"abstract":"<div><p>Solitary fibrous tumor (SFT) is a rare neoplasm. Liver parenchyma is a rare location of SFT and, in this case, it usually follows a benign course. We report here the case of a 54-year-old man who presented a large SFT tumor of the right hepatic lobe. The tumor was surgically resected. Local recurrence occurred 6 years later as a 15 cm diameter liver tumor. Histological examination of the resected lesion showed features of an aggressive form of SFT. Two years later, the patient presented with complaints of neck pain and ensuing examinations revealed a tumor of the cranial base. A new surgical resection was performed and histological examination confirmed a metastasis of the SFT. Few weeks later, the patient presented an irreducible psoitis due to an iliac bone metastasis. He died within 1 month.</p></div><div><p>La tumeur fibreuse solitaire est une néoplasie rare. Sa localisation hépatique est peu fréquente et, dans ce cas, est le plus souvent bénigne. Nous rapportons le cas d’un homme de 54 ans ayant présenté une volumineuse tumeur fibreuse solitaire du foie droit. Après un traitement chirurgical initial la tumeur récidivait six ans plus tard sous forme d’une lésion de 15 cm. L’analyse histologique montrait des caractéristiques en faveur d’une forme agressive. Deux ans plus tard, le patient a consulté pour des cervicalgies. Les examens réalisés ont révélé une tumeur de la base du crâne. Une nouvelle résection chirurgicale a été réalisée et l’histologie était en faveur d’une métastase de la tumeur fibreuse solitaire du foie. Quelques semaines plus tard, le patient a présenté un psoïtis irréductible en lien avec une métastase osseuse iliaque. Il est décédé un mois plus tard.</p></div>","PeriodicalId":12508,"journal":{"name":"Gastroenterologie Clinique Et Biologique","volume":"34 12","pages":"Pages 716-720"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gcb.2010.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29298296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
期刊
Gastroenterologie Clinique Et Biologique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1